| 7302 | A | 062154 | 001 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | TRIMOX | APOTHECON | 125MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | fe85839abc8bb202c91c15fcc19b1a4917aa5ddc1095a3a3bca646f92298454b |
| 7303 | A | 062885 | 001 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | TRIMOX | APOTHECON | 125MG/5ML | | [] | 1988-03-08 | Mar 8, 1988 | No | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 7d7f9e6068ad4b7b35727bcb3266d2e53f8cc41531abfdfece46a5ced7782d21 |
| 7304 | A | 061886 | 003 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | TRIMOX | APOTHECON | 250MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 05e469f01e7103f1d8da1437b66c0faf427cd6d7c3b7b87ee5967cc3a999993a |
| 7305 | A | 062099 | 002 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | TRIMOX | APOTHECON | 250MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | 95e9ade0cea48ff9ffa07f1cf73b1e0d638820f0f31e36207b569928bab7e24b |
| 7306 | A | 062154 | 002 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | TRIMOX | APOTHECON | 250MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | 278b47abc702c3431f630eb533312eb8a7bfc9595c0816e13b0aa6a0935867f7 |
| 7307 | A | 062885 | 002 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | TRIMOX | APOTHECON | 250MG/5ML | | [] | 1988-03-08 | Mar 8, 1988 | No | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 9883fccbca40ef074a84e15e957c743c7685e9575053e218dd8b2ddddd457362 |
| 7308 | A | 062376 | 001 | CEFADROXIL/CEFADROXIL HEMIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ULTRACEF | BRISTOL | EQ 125MG BASE/5ML | | [] | 1982-03-16 | Mar 16, 1982 | No | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 501aeab226c363291d54b56b9c9910c46f35e7cafeab18ab74af06c5df5ba85a |
| 7309 | A | 062376 | 002 | CEFADROXIL/CEFADROXIL HEMIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ULTRACEF | BRISTOL | EQ 250MG BASE/5ML | | [] | 1982-03-16 | Mar 16, 1982 | No | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | cbd3703e8e9fe308d1027532cd7cc00b0da504e2b784a5168ea1aee3148ff6e2 |
| 7310 | A | 062376 | 003 | CEFADROXIL/CEFADROXIL HEMIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ULTRACEF | BRISTOL | EQ 500MG BASE/5ML | | [] | 1982-03-16 | Mar 16, 1982 | No | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 8f54b63f51d94bee3afa545c761a9e69b7d32c45a22fa9eb2f53b16498910212 |
| 7311 | A | 062127 | 001 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | UTIMOX | PARKE DAVIS | 125MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PARKE DAVIS DIV WARNER LAMBERT CO | 5b3d476541036dac3ad07b6707f52faad1a93829d6e15c1e7c8b94405a46ca27 |
| 7312 | A | 062127 | 002 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | UTIMOX | PARKE DAVIS | 250MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PARKE DAVIS DIV WARNER LAMBERT CO | 3ae2da5ef3a50874b853febd01c891ea01ca84e87de480c1089d86c8ad580033 |
| 7313 | A | 060002 | 001 | PENICILLIN V | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | V-CILLIN | LILLY | 125MG/0.6ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ELI LILLY AND CO | 4533ed5a1310727db34edada3e4ab9e109e80e3e78e0686ac30a0b3a2ee30517 |
| 7314 | N | 050675 | 001 | CEFPODOXIME PROXETIL | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VANTIN | PHARMACIA AND UPJOHN | EQ 50MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1992-08-07 | Aug 7, 1992 | No | Yes | No | DISCN | PHARMACIA AND UPJOHN CO | c49b5cc3440070447940be75240091c49f7aa1a0e035d2836cf3a9c8eca81b21 |
| 7315 | N | 050675 | 002 | CEFPODOXIME PROXETIL | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VANTIN | PHARMACIA AND UPJOHN | EQ 100MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1992-08-07 | Aug 7, 1992 | No | Yes | No | DISCN | PHARMACIA AND UPJOHN CO | 993b5878138e3fa8bea513b4f5ca191d28ac830ce04176902ddcff5b954f658d |
| 7316 | N | 208036 | 004 | BARIUM SULFATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VARIBAR THIN LIQUID | BRACCO | 81% (120GM/BOT) | | [] | 2019-04-30 | Apr 30, 2019 | No | Yes | Yes | RX | BRACCO DIAGNOSTICS INC | 8b73c7fad7b8a11a58cdad81758e0c43b974110b5dabae93c637df7dc531db5a |
| 7317 | A | 061763 | 001 | CEPHRADINE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VELOSEF '125' | APOTHECON | 125MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | bcaa1aca6bbcaa56ff4fcfcbeeaf17bd4d69c62aada45953a71fa3e24edae010 |
| 7318 | A | 061763 | 002 | CEPHRADINE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VELOSEF '250' | APOTHECON | 250MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 76be60da7480ff5f82503d98f856bbd9e8c179d399b27a6454f62be7ed27e3c6 |
| 7319 | A | 061398 | 001 | HETACILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VERSAPEN | BRISTOL | EQ 112.5MG AMPICIL/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 10dbe6bf515eb5c66931e52b1a1964dd53a5ee326eadcb53776b3d0f461c0a95 |
| 7320 | N | 050060 | 001 | HETACILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VERSAPEN | BRISTOL | EQ 112.5MG AMPICIL/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | 5bc6e2df87c8fcb80386ab4ad313c471f7cfcfeee93d638b332f819fa3a01a72 |
| 7321 | N | 050060 | 003 | HETACILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VERSAPEN | BRISTOL | EQ 112.5MG AMPICIL/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | eb3b4f432afd00fad11210c4c010d58d01f1bc55700e13c6afbfa667d8b4277f |
| 7322 | A | 061398 | 002 | HETACILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VERSAPEN | BRISTOL | EQ 225MG AMPICIL/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | f3f39f6aaa2164a3b5a2254258723dcc085d0e2d521a5251b3aec2561ae44f47 |
| 7323 | N | 021630 | 001 | VORICONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VFEND | PF PRISM CV | 200MG/5ML | AB | ["AB"] | 2003-12-19 | Dec 19, 2003 | No | Yes | Yes | RX | PF PRISM CV | ac92b04a2aba6b7c8f90d800a2840ad5b41ba1bd156034c944679b9cf26e0491 |
| 7324 | N | 050006 | 001 | DOXYCYCLINE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VIBRAMYCIN | PFIZER | EQ 25MG BASE/5ML | AB | ["AB"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | PFIZER LABORATORIES DIV PFIZER INC | 5af17a049ab7b0570e3535884684cc1f7021920c0835482e69bc0539c523b8a3 |
| 7325 | A | 205034 | 001 | VORICONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VORICONAZOLE | AMNEAL PHARMS | 200MG/5ML | AB | ["AB"] | 2016-04-13 | Apr 13, 2016 | No | No | No | RX | AMNEAL PHARMACEUTICALS | 03cc3aa7718ebb798a5b8fd106eea68830fd4b403b0353be691839dbdf3f71ce |
| 7326 | A | 202361 | 001 | VORICONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VORICONAZOLE | MYLAN PHARMS INC | 200MG/5ML | | [] | 2013-05-28 | May 28, 2013 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 5dfddaa087a052004e61358876891415509f5438bea66cbb00918fd15378cf10 |
| 7327 | A | 206799 | 001 | VORICONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | VORICONAZOLE | NOVEL LABS INC | 200MG/5ML | AB | ["AB"] | 2016-05-31 | May 31, 2016 | No | No | No | RX | NOVEL LABORATORIES INC | a31e8ea30ee3336424cc8343f2f706b14ad5164e9d01431721dc48531a0d3763 |
| 7328 | N | 022362 | 001 | COLESEVELAM HYDROCHLORIDE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | WELCHOL | DAIICHI SANKYO | 1.875GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2009-10-02 | Oct 2, 2009 | No | Yes | No | DISCN | DAIICHI SANKYO INC | 3bd9231aad929bbefd82e744c13b57f206d8f9f7920e4135109cf8e188c65888 |
| 7329 | N | 022362 | 002 | COLESEVELAM HYDROCHLORIDE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | WELCHOL | DAIICHI SANKYO | 3.75GM/PACKET | AB | ["AB"] | 2009-10-02 | Oct 2, 2009 | No | Yes | Yes | RX | DAIICHI SANKYO INC | 5df4ec8e0ac267de03a90f54a338ef0d491e3afb23edbdfbe6ae3612b1076674 |
| 7330 | A | 062131 | 001 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | WYMOX | WYETH AYERST | 125MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | adc4849c0f10889248528fd04dee26ec531f5e7fd521479445d388343e32263a |
| 7331 | A | 062131 | 002 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | WYMOX | WYETH AYERST | 250MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | e793bb7d54405bb5703640b8be8681004accaa1d92310ec293c71518908a5e21 |
| 7332 | N | 214410 | 001 | BALOXAVIR MARBOXIL | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | XOFLUZA | GENENTECH INC | 2MG/ML | | [] | 2020-11-23 | Nov 23, 2020 | No | Yes | Yes | RX | GENENTECH INC | 110c4ce2a62e64d8b85947f0662b3f900878fc84753fc3503ca4c8d505db7ff1 |
| 7333 | N | 021636 | 001 | OMEPRAZOLE; SODIUM BICARBONATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ZEGERID | SALIX | 20MG/PACKET;1.68GM/PACKET | AB | ["AB"] | 2004-06-15 | Jun 15, 2004 | No | Yes | No | RX | SALIX PHARMACEUTICALS INC | 6493c3c280be97e16ed54d7a9e635a4cd3117c93d728d4bea0d09f2a5c807684 |
| 7334 | N | 021636 | 002 | OMEPRAZOLE; SODIUM BICARBONATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ZEGERID | SALIX | 40MG/PACKET;1.68GM/PACKET | AB | ["AB"] | 2004-12-21 | Dec 21, 2004 | No | Yes | Yes | RX | SALIX PHARMACEUTICALS INC | 9da265f31d536d8f84a83d44a37bd4769937583df47d59667a3fafae8c12eda6 |
| 7335 | N | 022283 | 001 | OMEPRAZOLE; SODIUM BICARBONATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ZEGERID OTC | BAYER HEALTHCARE LLC | 20MG/PACKET;1.68GM/PACKET | | [] | 2013-06-17 | Jun 17, 2013 | No | Yes | Yes | OTC | BAYER HEALTHCARE LLC | c894121762f33c2cb9996043fb97bd87aa583c5221f4aba625d49b2a80f9942d |
| 7336 | N | 050693 | 001 | AZITHROMYCIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ZITHROMAX | PFIZER | EQ 1GM BASE/PACKET | | [] | 1994-09-28 | Sep 28, 1994 | No | Yes | Yes | RX | PFIZER CENTRAL RESEARCH | 4e4f16055d1db5ef7a7d89adfb1c788e2a2bec90b8544fe196e11536bf730cf1 |
| 7337 | N | 050710 | 001 | AZITHROMYCIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ZITHROMAX | PFIZER | EQ 100MG BASE/5ML | AB | ["AB"] | 1995-10-19 | Oct 19, 1995 | No | Yes | No | RX | PFIZER CHEMICALS DIV PFIZER INC | b527d6ff9f5ad5bef2544a532e2be6fd6e5a792ec7a237d7dbf939fab0f0c376 |
| 7338 | N | 050710 | 002 | AZITHROMYCIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ZITHROMAX | PFIZER | EQ 200MG BASE/5ML | AB | ["AB"] | 1995-10-19 | Oct 19, 1995 | No | Yes | Yes | RX | PFIZER CHEMICALS DIV PFIZER INC | 5b6aa6b88e50460cbc1116907c3f36e2b94100fc8eae62dd316458d11f46d4c1 |
| 7339 | N | 021132 | 001 | LINEZOLID | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ZYVOX | PFIZER | 100MG/5ML | AB | ["AB"] | 2000-04-18 | Apr 18, 2000 | No | Yes | Yes | RX | PFIZER INC | 9c2c2c34cbf93f011f714568db8ec1ab9b7691a63f37d3e187ea46e7306b6d11 |
| 7340 | N | 202860 | 001 | NITRIC OXIDE | GAS;INHALATION | GAS | INHALATION | GENOSYL | VERO BIOTECH | 800PPM | | [] | 2019-12-20 | Dec 20, 2019 | No | Yes | Yes | RX | VERO BIOTECH | 0f129482784739e5fe1a70d2eb8f917e406b4a5495121cbabed977b8d6a75020 |
| 7341 | N | 020845 | 002 | NITRIC OXIDE | GAS;INHALATION | GAS | INHALATION | INOMAX | MALLINCKRODT HOSP | 100PPM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1999-12-23 | Dec 23, 1999 | No | Yes | No | DISCN | MALLINCKRODT HOSP PRODUCTS IP LTD | a97bfba4d1fff70223bcf328d7f56740b2d71b2891d979aca26a95dd08e4bca9 |
| 7342 | N | 020845 | 003 | NITRIC OXIDE | GAS;INHALATION | GAS | INHALATION | INOMAX | MALLINCKRODT HOSP | 800PPM | AA | ["AA"] | 1999-12-23 | Dec 23, 1999 | No | Yes | Yes | RX | MALLINCKRODT HOSP PRODUCTS IP LTD | 9ca607734a10d36e56d0c066fcf186b47f036657f8521376f0665daf3d7f4c1d |
| 7343 | N | 018088 | 001 | KRYPTON, KR-81M | GAS;INHALATION | GAS | INHALATION | MPI KRYPTON 81M GENERATOR | GE HEALTHCARE | N/A | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GE HEALTHCARE | a2c5a0160016fff2724d22bf8f1feb06bf309fa54779ba058e394d5914c01f6b |
| 7344 | A | 207141 | 001 | NITRIC OXIDE | GAS;INHALATION | GAS | INHALATION | NOXIVENT | PRAXAIR DISTRIBUTION | 100PPM | | [] | 2018-10-02 | Oct 2, 2018 | No | No | No | RX | PRAXAIR DISTRIBUTION INC | 4eef81f5fea55ab48c02183e36e36636554073c70caf346dd2422fa92b02936f |
| 7345 | A | 207141 | 002 | NITRIC OXIDE | GAS;INHALATION | GAS | INHALATION | NOXIVENT | PRAXAIR DISTRIBUTION | 800PPM | AA | ["AA"] | 2018-10-02 | Oct 2, 2018 | No | No | No | RX | PRAXAIR DISTRIBUTION INC | d3a3610dfcff0c5534591683c337f6542ea2dac2f26387761991a4c28c3324f2 |
| 7346 | N | 018536 | 001 | XENON XE-127 | GAS;INHALATION | GAS | INHALATION | XENON XE 127 | MALLINCKRODT | 5mCi/VIAL | | [] | 1982-10-01 | Oct 1, 1982 | No | No | No | DISCN | MALLINCKRODT MEDICAL INC | de316de2eb33f4c2eebbc92e77ba62c02fbdc537c9eecc2ea472f8dbc37f05a9 |
| 7347 | N | 018536 | 002 | XENON XE-127 | GAS;INHALATION | GAS | INHALATION | XENON XE 127 | MALLINCKRODT | 10mCi/VIAL | | [] | 1982-10-01 | Oct 1, 1982 | No | No | No | DISCN | MALLINCKRODT MEDICAL INC | 51b002563673e7019cc02aad7a9c4d19f99f44476dbb889899b03e8807ceed59 |
| 7348 | N | 018327 | 001 | XENON XE-133 | GAS;INHALATION | GAS | INHALATION | XENON XE 133 | CURIUM | 10mCi/VIAL | | [] | 1982-03-09 | Mar 9, 1982 | No | No | No | RX | CURIUM US LLC | 5831f42620bfc6d5c12cb9b2ec9308958924c55fed2b5c9c19660a7aad9c2cc6 |
| 7349 | N | 018327 | 002 | XENON XE-133 | GAS;INHALATION | GAS | INHALATION | XENON XE 133 | CURIUM | 20mCi/VIAL | | [] | 1982-03-09 | Mar 9, 1982 | No | No | No | RX | CURIUM US LLC | ca7513671aedc4a5119d908cf54aa3e25cf34f095aabcd17e467878839faf881 |
| 7350 | N | 017256 | 002 | XENON XE-133 | GAS;INHALATION | GAS | INHALATION | XENON XE 133 | GE HEALTHCARE | 1 CI/AMP | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GE HEALTHCARE | b273b0898f232a0e856dadbede8000879e89318246de09f0a5a252c17706c691 |
| 7351 | N | 017687 | 002 | XENON XE-133 | GAS;INHALATION | GAS | INHALATION | XENON XE 133 | GE HEALTHCARE | 10mCi/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GE HEALTHCARE | 108e11914385020ef6ce0ca45a3004c5dc24b2b44cedc43722caa874a29a208a |